ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells

Cell Reports

Volumn 13, Issue 8, 2015, Pages 1623-1632

  Lee, Stella Suyong ^a   Bohrson, Craig ^a   Pike, Alexandra Mims ^a   Wheelan, Sarah Jo ^a   Greider, Carol Widney ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OLAPARIB; TELOMERASE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; ASSAY; CELL CYCLE ARREST; CELL DEATH; CELL REGENERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TELOMERE ELONGATION; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; ANIMAL; CELL LINE; METABOLISM; TELOMERE;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; HUMANS; MICE; POLY(ADP-RIBOSE) POLYMERASES; TELOMERASE; TELOMERE;

EID: 84952874391     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.10.035     Document Type: Article

References (67)

1. Armanios M., Blackburn E.H. The telomere syndromes. Nat. Rev. Genet. 2012, 13:693-704.
2. Artandi S.E., DePinho R.A. Telomeres and telomerase in cancer. Carcinogenesis 2010, 31:9-18.
3. Autexier C., Greider C.W. Boundary elements of the Tetrahymena telomerase RNA template and alignment domains. Genes Dev. 1995, 9:2227-2239.
4. Baird D.M., Davis T., Rowson J., Jones C.J., Kipling D. Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells. Hum. Mol. Genet. 2004, 13:1515-1524.
5. Banerjee S., Kaye S.B., Ashworth A. Making the best of PARP inhibitors in ovarian cancer. Nat. Rev. Clin. Oncol. 2010, 7:508-519.
6. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
7. Bryant H.E., Helleday T. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res. 2006, 34:1685-1691.
8. Carneiro M.O., Russ C., Ross M.G., Gabriel S.B., Nusbaum C., DePristo M.A. Pacific biosciences sequencing technology for genotyping and variation discovery in human data. BMC Genomics 2012, 13:375.
9. Chan S.W., Chang J., Prescott J., Blackburn E.H. Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr. Biol. 2001, 11:1240-1250.
10. Chen J.-L., Greider C.W. Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility. EMBO J. 2003, 22:304-314.
11. Chen J.L., Greider C.W. Template boundary definition in mammalian telomerase. Genes Dev. 2003, 17:2747-2752.
12. Chiang Y.J., Hsiao S.J., Yver D., Cushman S.W., Tessarollo L., Smith S., Hodes R.J. Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS ONE 2008, 3:e2639.
13. Cook B.D., Dynek J.N., Chang W., Shostak G., Smith S. Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol. Cell. Biol. 2002, 22:332-342.
14. Cristofari G., Lingner J. Telomere length homeostasis requires that telomerase levels are limiting. EMBO J. 2006, 25:565-574.
15. d'Adda di Fagagna F., Hande M.P., Tong W.M., Roth D., Lansdorp P.M., Wang Z.Q., Jackson S.P. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 2001, 11:1192-1196.
16. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
17. Daniel J.A., Pellegrini M., Lee B.S., Guo Z., Filsuf D., Belkina N.V., You Z., Paull T.T., Sleckman B.P., Feigenbaum L., Nussenzweig A. Loss of ATM kinase activity leads to embryonic lethality in mice. J. Cell Biol. 2012, 198:295-304.
18. de Lange T. How telomeres solve the end-protection problem. Science 2009, 326:948-952.
19. Diede S.J., Gottschling D.E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta. Cell 1999, 99:723-733.
20. Farr C., Fantes J., Goodfellow P., Cooke H. Functional reintroduction of human telomeres into mammalian cells. Proc. Natl. Acad. Sci. USA 1991, 88:7006-7010.
21. Feldser D., Strong M.A., Greider C.W. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres. Proc. Natl. Acad. Sci. USA 2006, 103:2249-2251.
22. Fong P.C., Boss D.S., Yap T.A., Tutt A., Wu P., Mergui-Roelvink M., Mortimer P., Swaisland H., Lau A., O'Connor M.J., et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 2009, 361:123-134.
23. Frank C.J., Hyde M., Greider C.W. Regulation of telomere elongation by the cyclin-dependent kinase CDK1. Mol. Cell 2006, 24:423-432.
24. Greenwell P.W., Kronmal S.L., Porter S.E., Gassenhuber J., Obermaier B., Petes T.D. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 1995, 82:823-829.
25. Greider C.W. Telomerase is processive. Mol. Cell. Biol. 1991, 11:4572-4580.
26. Greider C.W. Telomerase activation. One step on the road to cancer?. Trends Genet. 1999, 15:109-112.
27. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
28. Hande M.P., Balajee A.S., Tchirkov A., Wynshaw-Boris A., Lansdorp P.M. Extra-chromosomal telomeric DNA in cells from Atm(-/-) mice and patients with ataxia-telangiectasia. Hum. Mol. Genet. 2001, 10:519-528.
29. Hao L.Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., Greider C.W. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 2005, 123:1121-1131.
30. Harrington L.A., Greider C.W. Telomerase primer specificity and chromosome healing. Nature 1991, 353:451-454.
31. Hickson I., Zhao Y., Richardson C.J., Green S.J., Martin N.M., Orr A.I., Reaper P.M., Jackson S.P., Curtin N.J., Smith G.C. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004, 64:9152-9159.
32. Hsiao S.J., Poitras M.F., Cook B.D., Liu Y., Smith S. Tankyrase 2 poly(ADP-ribose) polymerase domain-deleted mice exhibit growth defects but have normal telomere length and capping. Mol. Cell. Biol. 2006, 26:2044-2054.
33. Kang S.S., Kwon T., Kwon D.Y., Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 1999, 274:13085-13090.
34. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283:1321-1325.
35. Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 2000, 1:179-186.
36. Kim G., Ison G., McKee A.E., Zhang H., Tang S., Gwise T., Sridhara R., Lee E., Tzou A., Philip R., et al. FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy. Clin. Cancer Res. 2015, 21:4257-4261.
37. Kramer K.M., Haber J.E. New telomeres in yeast are initiated with a highly selected subset of TG1-3 repeats. Genes Dev. 1993, 7(12A):2345-2356.
38. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
39. Loomis E.W., Eid J.S., Peluso P., Yin J., Hickey L., Rank D., McCalmon S., Hagerman R.J., Tassone F., Hagerman P.J. Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res. 2013, 23:121-128.
40. Ma Y., Greider C.W. Kinase-independent functions of TEL1 in telomere maintenance. Mol. Cell. Biol. 2009, 29:5193-5202.
41. Metcalfe J.A., Parkhill J., Campbell L., Stacey M., Biggs P., Byrd P.J., Taylor A.M. Accelerated telomere shortening in ataxia telangiectasia. Nat. Genet. 1996, 13:350-353.
42. Morin G.B. Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase. Nature 1991, 353:454-456.
43. Morrish T.A., Greider C.W. Short telomeres initiate telomere recombination in primary and tumor cells. PLoS Genet. 2009, 5:e1000357.
44. Moser B.A., Chang Y.T., Kosti J., Nakamura T.M. Tel1ATM and Rad3ATR kinases promote Ccq1-Est1 interaction to maintain telomeres in fission yeast. Nat. Struct. Mol. Biol. 2011, 18:1408-1413.
45. Naito T., Matsuura A., Ishikawa F. Circular chromosome formation in a fission yeast mutant defective in two ATM homologues. Nat. Genet. 1998, 20:203-206.
46. Nakamura T.M., Moser B.A., Russell P. Telomere binding of checkpoint sensor and DNA repair proteins contributes to maintenance of functional fission yeast telomeres. Genetics 2002, 161:1437-1452.
47. Nandakumar J., Bell C.F., Weidenfeld I., Zaug A.J., Leinwand L.A., Cech T.R. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature 2012, 492:285-289.
48. Palm W., de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
49. Paull T.T. Mechanisms of ATM Activation. Annu. Rev. Biochem. 2015, 84:711-738.
50. Reaper P.M., Griffiths M.R., Long J.M., Charrier J.D., Maccormick S., Charlton P.A., Golec J.M., Pollard J.R. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nat. Chem. Biol. 2011, 7:428-430.
51. Ritchie K.B., Mallory J.C., Petes T.D. Interactions of TLC1 (which encodes the RNA subunit of telomerase), TEL1, and MEC1 in regulating telomere length in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 1999, 19:6065-6075.
52. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995, 268:1749-1753.
53. Seimiya H., Smith S. The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182). J. Biol. Chem. 2002, 277:14116-14126.
54. Shiloh Y., Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 2013, 14:197-210.
55. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 2002, 21:4338-4348.
56. Smogorzewska A., de Lange T. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 2004, 73:177-208.
57. Sprung C.N., Bryan T.M., Reddel R.R., Murnane J.P. Normal telomere maintenance in immortal ataxia telangiectasia cell lines. Mutat. Res. 1997, 379:177-184.
58. Tchirkov A., Lansdorp P.M. Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum. Mol. Genet. 2003, 12:227-232.
59. Tong A.S., Stern J.L., Sfeir A., Kartawinata M., de Lange T., Zhu X.D., Bryan T.M. ATM and ATR signaling regulate the recruitment of human telomerase to telomeres. Cell Rep. 2015, 13. Published online November 12, 2015. 10.1016/j.celrep.2015.10.041.
60. Underhill C., Toulmonde M., Bonnefoi H. A review of PARP inhibitors: from bench to bedside. Ann. Oncol. 2011, 22:268-279.
61. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 1997, 16:6018-6033.
62. Wahlberg E., Karlberg T., Kouznetsova E., Markova N., Macchiarulo A., Thorsell A.G., Pol E., Frostell Å., Ekblad T., Öncü D., et al. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat. Biotechnol. 2012, 30:283-288.
63. Wang F., Podell E.R., Zaug A.J., Yang Y., Baciu P., Cech T.R., Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007, 445:506-510.
64. Wu Y., Xiao S., Zhu X.D. MRE11-RAD50-NBS1 and ATM function as co-mediators of TRF1 in telomere length control. Nat. Struct. Mol. Biol. 2007, 14:832-840.
65. Xia S.J., Shammas M.A., Shmookler Reis R.J. Reduced telomere length in ataxia-telangiectasia fibroblasts. Mutat. Res. 1996, 364:1-11.
66. Yamamoto K., Wang Y., Jiang W., Liu X., Dubois R.L., Lin C.S., Ludwig T., Bakkenist C.J., Zha S. Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice. J. Cell Biol. 2012, 198:305-313.
67. Yamazaki H., Tarumoto Y., Ishikawa F. Tel1(ATM) and Rad3(ATR) phosphorylate the telomere protein Ccq1 to recruit telomerase and elongate telomeres in fission yeast. Genes Dev. 2012, 26:241-246.